• レポートコード:QY20ST-09817 • 出版社/出版日:QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、149ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の動物生物学的ワクチン市場について種類別(経口、皮下、筋肉内、その他)、用途別(Porcine、 Poultry、 Livestock、 Companion Animals、 Aquaculture)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・動物生物学的ワクチン市場の概要 ・世界の主要地域別動物生物学的ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の動物生物学的ワクチン市場規模2015-2026:種類別(経口、皮下、筋肉内、その他) ・世界の動物生物学的ワクチン市場規模2015-2026:用途別(Porcine、 Poultry、 Livestock、 Companion Animals、 Aquaculture) ・動物生物学的ワクチンの北米市場規模2015-2020 ・動物生物学的ワクチンのヨーロッパ市場規模2015-2020 ・動物生物学的ワクチンの中国市場規模2015-2020 ・動物生物学的ワクチンの日本市場規模2015-2020 ・動物生物学的ワクチンの東南アジア市場規模2015-2020 ・動物生物学的ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・動物生物学的ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・動物生物学的ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Animal Biological Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Animal Biological Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Animal Biological Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Animal Biological Vaccine industry.
Based on our recent survey, we have several different scenarios about the Animal Biological Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Animal Biological Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Animal Biological Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Animal Biological Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Animal Biological Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Animal Biological Vaccine market. The report also includes nautical information, where it shows Animal Biological Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Animal Biological Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Animal Biological Vaccine market.
Geographical Analysis:
Based on region, the global Animal Biological Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Animal Biological Vaccine market are
Merck
Zoetis
Merial/Sanofi
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Porcine
Poultry
Livestock
Companion Animals
Aquaculture
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Animal Biological Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Animal Biological Vaccine market.
• The market share of the global Animal Biological Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Animal Biological Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Animal Biological Vaccine market.
1 Animal Biological Vaccine Market Overview
1.1 Animal Biological Vaccine Product Scope
1.2 Animal Biological Vaccine Segment by Type
1.2.1 Global Animal Biological Vaccine Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Animal Biological Vaccine Segment by Application
1.3.1 Global Animal Biological Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Porcine
1.3.3 Poultry
1.3.4 Livestock
1.3.5 Companion Animals
1.3.6 Aquaculture
1.4 Animal Biological Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Animal Biological Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Animal Biological Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Animal Biological Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Animal Biological Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Animal Biological Vaccine Industry
1.5.1.1 Animal Biological Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Animal Biological Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Animal Biological Vaccine Players to Combat Covid-19 Impact
2 Animal Biological Vaccine Estimate and Forecast by Region
2.1 Global Animal Biological Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Animal Biological Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Animal Biological Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Animal Biological Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Animal Biological Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Animal Biological Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Animal Biological Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Animal Biological Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Animal Biological Vaccine Estimates and Projections (2015-2026)
2.4.3 China Animal Biological Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Animal Biological Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Animal Biological Vaccine Estimates and Projections (2015-2026)
2.4.6 India Animal Biological Vaccine Estimates and Projections (2015-2026)
3 Global Animal Biological Vaccine Competition Landscape by Players
3.1 Global Top Animal Biological Vaccine Players by Sales (2015-2020)
3.2 Global Top Animal Biological Vaccine Players by Revenue (2015-2020)
3.3 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Biological Vaccine as of 2019)
3.4 Global Animal Biological Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Animal Biological Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Animal Biological Vaccine Players (Opinion Leaders)
4 Global Animal Biological Vaccine Market Size by Type
4.1 Global Animal Biological Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Animal Biological Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Animal Biological Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Animal Biological Vaccine Price by Type (2014-2020)
4.2 Global Animal Biological Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Animal Biological Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Biological Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Animal Biological Vaccine Price Forecast by Type (2021-2026)
5 Global Animal Biological Vaccine Market Size by Application
5.1 Global Animal Biological Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Animal Biological Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Animal Biological Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Animal Biological Vaccine Price by Application (2015-2020)
5.2 Global Animal Biological Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Animal Biological Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Biological Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Biological Vaccine Price Forecast by Application (2021-2026)
3 North America Animal Biological Vaccine Market Facts & Figures
3.2 North America Animal Biological Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Animal Biological Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Animal Biological Vaccine Sales Market Share by Application (2015-2020)
4 Europe Animal Biological Vaccine Market Facts & Figures
4.2 Europe Animal Biological Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Animal Biological Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Animal Biological Vaccine Sales Market Share by Application (2015-2020)
5 China Animal Biological Vaccine Market Facts & Figures
5.2 China Animal Biological Vaccine Sales Market Share by Company (2015-2020)
5.3 China Animal Biological Vaccine Sales Market Share by Type (2015-2020)
5.4 China Animal Biological Vaccine Sales Market Share by Application (2015-2020)
6 Japan Animal Biological Vaccine Market Facts & Figures
6.2 Japan Animal Biological Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Animal Biological Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Animal Biological Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Animal Biological Vaccine Market Facts & Figures
7.2 Southeast Asia Animal Biological Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Animal Biological Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Animal Biological Vaccine Sales Market Share by Application (2015-2020)
8 India Animal Biological Vaccine Market Facts & Figures
8.2 India Animal Biological Vaccine Sales Market Share by Company (2015-2020)
8.3 India Animal Biological Vaccine Sales Market Share by Type (2015-2020)
8.4 India Animal Biological Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Animal Biological Vaccine Business
12.1 Merck
12.1.1 Merck Animal Biological Vaccine Corporation Information
12.1.2 Merck Animal Biological Vaccine Business Overview and Total Revenue
12.1.3 Merck Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Animal Biological Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Zoetis
12.2.1 Zoetis Animal Biological Vaccine Corporation Information
12.2.2 Zoetis Animal Biological Vaccine Business Overview and Total Revenue
12.2.3 Zoetis Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Zoetis Animal Biological Vaccine Products Offered
12.2.5 Zoetis Recent Development
12.3 Merial/Sanofi
12.3.1 Merial/Sanofi Animal Biological Vaccine Corporation Information
12.3.2 Merial/Sanofi Animal Biological Vaccine Business Overview and Total Revenue
12.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merial/Sanofi Animal Biological Vaccine Products Offered
12.3.5 Merial/Sanofi Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Animal Biological Vaccine Corporation Information
12.4.2 Boehringer Ingelheim Animal Biological Vaccine Business Overview and Total Revenue
12.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boehringer Ingelheim Animal Biological Vaccine Products Offered
12.4.5 Boehringer Ingelheim Recent Development
12.5 Ceva
12.5.1 Ceva Animal Biological Vaccine Corporation Information
12.5.2 Ceva Animal Biological Vaccine Business Overview and Total Revenue
12.5.3 Ceva Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Ceva Animal Biological Vaccine Products Offered
12.5.5 Ceva Recent Development
12.6 CAHIC
12.6.1 CAHIC Animal Biological Vaccine Corporation Information
12.6.2 CAHIC Animal Biological Vaccine Business Overview and Total Revenue
12.6.3 CAHIC Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CAHIC Animal Biological Vaccine Products Offered
12.6.5 CAHIC Recent Development
12.7 HVRI
12.7.1 HVRI Animal Biological Vaccine Corporation Information
12.7.2 HVRI Animal Biological Vaccine Business Overview and Total Revenue
12.7.3 HVRI Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 HVRI Animal Biological Vaccine Products Offered
12.7.5 HVRI Recent Development
12.8 Ringpu Biology
12.8.1 Ringpu Biology Animal Biological Vaccine Corporation Information
12.8.2 Ringpu Biology Animal Biological Vaccine Business Overview and Total Revenue
12.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ringpu Biology Animal Biological Vaccine Products Offered
12.8.5 Ringpu Biology Recent Development
12.9 Yebio
12.9.1 Yebio Animal Biological Vaccine Corporation Information
12.9.2 Yebio Animal Biological Vaccine Business Overview and Total Revenue
12.9.3 Yebio Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Yebio Animal Biological Vaccine Products Offered
12.9.5 Yebio Recent Development
12.10 DHN
12.10.1 DHN Animal Biological Vaccine Corporation Information
12.10.2 DHN Animal Biological Vaccine Business Overview and Total Revenue
12.10.3 DHN Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 DHN Animal Biological Vaccine Products Offered
12.10.5 DHN Recent Development
12.11 WINSUN
12.11.1 WINSUN Animal Biological Vaccine Corporation Information
12.11.2 WINSUN Animal Biological Vaccine Business Overview and Total Revenue
12.11.3 WINSUN Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 WINSUN Animal Biological Vaccine Products Offered
12.11.5 WINSUN Recent Development
12.12 Elanco/Eli Lilly
12.12.1 Elanco/Eli Lilly Animal Biological Vaccine Corporation Information
12.12.2 Elanco/Eli Lilly Animal Biological Vaccine Business Overview and Total Revenue
12.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Elanco/Eli Lilly Animal Biological Vaccine Products Offered
12.12.5 Elanco/Eli Lilly Recent Development
12.13 Virbac
12.13.1 Virbac Animal Biological Vaccine Corporation Information
12.13.2 Virbac Animal Biological Vaccine Business Overview and Total Revenue
12.13.3 Virbac Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Virbac Animal Biological Vaccine Products Offered
12.13.5 Virbac Recent Development
12.14 Jinyu Bio-Technology
12.14.1 Jinyu Bio-Technology Animal Biological Vaccine Corporation Information
12.14.2 Jinyu Bio-Technology Animal Biological Vaccine Business Overview and Total Revenue
12.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Jinyu Bio-Technology Animal Biological Vaccine Products Offered
12.14.5 Jinyu Bio-Technology Recent Development
12.15 ChengDu Tecbond
12.15.1 ChengDu Tecbond Animal Biological Vaccine Corporation Information
12.15.2 ChengDu Tecbond Animal Biological Vaccine Business Overview and Total Revenue
12.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 ChengDu Tecbond Animal Biological Vaccine Products Offered
12.15.5 ChengDu Tecbond Recent Development
12.16 CAVAC
12.16.1 CAVAC Animal Biological Vaccine Corporation Information
12.16.2 CAVAC Animal Biological Vaccine Business Overview and Total Revenue
12.16.3 CAVAC Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.16.4 CAVAC Animal Biological Vaccine Products Offered
12.16.5 CAVAC Recent Development
12.17 Kyoto Biken
12.17.1 Kyoto Biken Animal Biological Vaccine Corporation Information
12.17.2 Kyoto Biken Animal Biological Vaccine Business Overview and Total Revenue
12.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Kyoto Biken Animal Biological Vaccine Products Offered
12.17.5 Kyoto Biken Recent Development
12.18 FATRO
12.18.1 FATRO Animal Biological Vaccine Corporation Information
12.18.2 FATRO Animal Biological Vaccine Business Overview and Total Revenue
12.18.3 FATRO Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.18.4 FATRO Animal Biological Vaccine Products Offered
12.18.5 FATRO Recent Development
12.19 Vaksindo
12.19.1 Vaksindo Animal Biological Vaccine Corporation Information
12.19.2 Vaksindo Animal Biological Vaccine Business Overview and Total Revenue
12.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Vaksindo Animal Biological Vaccine Products Offered
12.19.5 Vaksindo Recent Development
12.20 Bio-Labs
12.20.1 Bio-Labs Animal Biological Vaccine Corporation Information
12.20.2 Bio-Labs Animal Biological Vaccine Business Overview and Total Revenue
12.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Bio-Labs Animal Biological Vaccine Products Offered
12.20.5 Bio-Labs Recent Development
12.21 Avimex Animal
12.21.1 Avimex Animal Animal Biological Vaccine Corporation Information
12.21.2 Avimex Animal Animal Biological Vaccine Business Overview and Total Revenue
12.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Avimex Animal Animal Biological Vaccine Products Offered
12.21.5 Avimex Animal Recent Development
13 Animal Biological Vaccine Manufacturing Cost Analysis
13.1 Animal Biological Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Animal Biological Vaccine
13.4 Animal Biological Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Animal Biological Vaccine Distributors List
14.3 Animal Biological Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Animal Biological Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Animal Biological Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Animal Biological Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Animal Biological Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Animal Biological Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Animal Biological Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Animal Biological Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Animal Biological Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Animal Biological Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Animal Biological Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Animal Biological Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Animal Biological Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Animal Biological Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Animal Biological Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Animal Biological Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Animal Biological Vaccine Sales Share by Company (2015-2020)
Table 19. Global Animal Biological Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Animal Biological Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Animal Biological Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Biological Vaccine as of 2019)
Table 22. Global Animal Biological Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Animal Biological Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Animal Biological Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Animal Biological Vaccine Players
Table 27. Global Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Animal Biological Vaccine Sales Share by Type (2015-2020)
Table 29. Global Animal Biological Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Animal Biological Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Animal Biological Vaccine Sales Share by Type (2021-2026)
Table 32. Global Animal Biological Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Animal Biological Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Animal Biological Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Animal Biological Vaccine Sales Share by Application (2015-2020)
Table 37. Global Animal Biological Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Animal Biological Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Animal Biological Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Animal Biological Vaccine Sales Share by Application (2021-2026)
Table 41. Global Animal Biological Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Animal Biological Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Animal Biological Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Animal Biological Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Animal Biological Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Animal Biological Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Animal Biological Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Animal Biological Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Animal Biological Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Animal Biological Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Animal Biological Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Animal Biological Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Animal Biological Vaccine Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Merck Animal Biological Vaccine Product
Table 84. Merck Recent Development
Table 85. Zoetis Corporation Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Zoetis Animal Biological Vaccine Product
Table 89. Zoetis Recent Development
Table 90. Merial/Sanofi Corporation Information
Table 91. Merial/Sanofi Description and Business Overview
Table 92. Merial/Sanofi Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Merial/Sanofi Animal Biological Vaccine Product
Table 94. Merial/Sanofi Recent Development
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Boehringer Ingelheim Animal Biological Vaccine Product
Table 99. Boehringer Ingelheim Recent Development
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Ceva Animal Biological Vaccine Product
Table 104. Ceva Recent Development
Table 105. CAHIC Corporation Information
Table 106. CAHIC Description and Business Overview
Table 107. CAHIC Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. CAHIC Animal Biological Vaccine Product
Table 109. CAHIC Recent Development
Table 110. HVRI Corporation Information
Table 111. HVRI Description and Business Overview
Table 112. HVRI Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. HVRI Animal Biological Vaccine Product
Table 114. HVRI Recent Development
Table 115. Ringpu Biology Corporation Information
Table 116. Ringpu Biology Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Ringpu Biology Description and Business Overview
Table 118. Ringpu Biology Animal Biological Vaccine Product
Table 119. Ringpu Biology Recent Development
Table 120. Yebio Corporation Information
Table 121. Yebio Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Yebio Description and Business Overview
Table 123. Yebio Animal Biological Vaccine Product
Table 124. Yebio Recent Development
Table 125. DHN Corporation Information
Table 126. DHN Description and Business Overview
Table 127. DHN Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. DHN Animal Biological Vaccine Product
Table 129. DHN Recent Development
Table 130. WINSUN Corporation Information
Table 131. WINSUN Description and Business Overview
Table 132. WINSUN Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. WINSUN Animal Biological Vaccine Product
Table 134. WINSUN Recent Development
Table 135. Elanco/Eli Lilly Corporation Information
Table 136. Elanco/Eli Lilly Description and Business Overview
Table 137. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Elanco/Eli Lilly Animal Biological Vaccine Product
Table 139. Elanco/Eli Lilly Recent Development
Table 140. Virbac Corporation Information
Table 141. Virbac Description and Business Overview
Table 142. Virbac Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Virbac Animal Biological Vaccine Product
Table 144. Virbac Recent Development
Table 145. Jinyu Bio-Technology Corporation Information
Table 146. Jinyu Bio-Technology Description and Business Overview
Table 147. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Jinyu Bio-Technology Animal Biological Vaccine Product
Table 149. Jinyu Bio-Technology Recent Development
Table 150. ChengDu Tecbond Corporation Information
Table 151. ChengDu Tecbond Description and Business Overview
Table 152. ChengDu Tecbond Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. ChengDu Tecbond Animal Biological Vaccine Product
Table 154. ChengDu Tecbond Recent Development
Table 155. CAVAC Corporation Information
Table 156. CAVAC Description and Business Overview
Table 157. CAVAC Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. CAVAC Animal Biological Vaccine Product
Table 159. CAVAC Recent Development
Table 160. Kyoto Biken Corporation Information
Table 161. Kyoto Biken Description and Business Overview
Table 162. Kyoto Biken Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 163. Kyoto Biken Animal Biological Vaccine Product
Table 164. Kyoto Biken Recent Development
Table 165. FATRO Corporation Information
Table 166. FATRO Description and Business Overview
Table 167. FATRO Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 168. FATRO Animal Biological Vaccine Product
Table 169. FATRO Recent Development
Table 170. Vaksindo Corporation Information
Table 171. Vaksindo Description and Business Overview
Table 172. Vaksindo Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 173. Vaksindo Animal Biological Vaccine Product
Table 174. Vaksindo Recent Development
Table 175. Bio-Labs Corporation Information
Table 176. Bio-Labs Description and Business Overview
Table 177. Bio-Labs Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 178. Bio-Labs Animal Biological Vaccine Product
Table 179. Bio-Labs Recent Development
Table . Avimex Animal Corporation Information
Table . Avimex Animal Description and Business Overview
Table . Avimex Animal Animal Biological Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Avimex Animal Animal Biological Vaccine Product
Table . Avimex Animal Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Animal Biological Vaccine Distributors List
Table 188. Animal Biological Vaccine Customers List
Table 189. Market Key Trends
Table 190. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 191. Key Challenges
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Biological Vaccine Product Picture
Figure 2. Global Animal Biological Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Animal Biological Vaccine Market Share by Application in 2020 & 2026
Figure 6. Porcine Examples
Figure 7. Poultry Examples
Figure 8. Livestock Examples
Figure 9. Companion Animals Examples
Figure 10. Aquaculture Examples
Figure 11. Global Animal Biological Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 12. Global Animal Biological Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Animal Biological Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 14. Global Animal Biological Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Animal Biological Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Animal Biological Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 18. Europe Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Animal Biological Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Animal Biological Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Animal Biological Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Animal Biological Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Animal Biological Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Animal Biological Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Animal Biological Vaccine Players Market Share by Revenue in Animal Biological Vaccine 2015 & 2019
Figure 29. Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Animal Biological Vaccine Revenue Share by Type (2015-2020)
Figure 31. Global Animal Biological Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Animal Biological Vaccine Revenue Share by Application (2015-2020)
Figure 33. Global Animal Biological Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 35. United States Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Animal Biological Vaccine Sales Market Share by Company in 2019
Figure 37. Europe Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 38. Europe Animal Biological Vaccine Sales Market Share by Application in 2019
Figure 39. China Animal Biological Vaccine Sales Market Share by Company in 2019
Figure 40. China Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 41. China Animal Biological Vaccine Sales Market Share by Application in 2019
Figure 42. Japan Animal Biological Vaccine Sales Market Share by Company in 2019
Figure 43. Japan Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 44. Japan Animal Biological Vaccine Sales Market Share by Application in 2019
Figure 45. Southeast Asia Animal Biological Vaccine Sales Market Share by Company in 2019
Figure 46. Southeast Asia Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 47. Southeast Asia Animal Biological Vaccine Sales Market Share by Application in 2019
Figure 48. India Animal Biological Vaccine Sales Market Share by Company in 2019
Figure 49. India Animal Biological Vaccine Sales Market Share by Type in 2019
Figure 50. India Animal Biological Vaccine Sales Market Share by Application in 2019
Figure 51. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merial/Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ceva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CAHIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. HVRI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Ringpu Biology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Yebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. DHN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. WINSUN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Elanco/Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Jinyu Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. ChengDu Tecbond Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Kyoto Biken Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. FATRO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Vaksindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Bio-Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Avimex Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Key Raw Materials Price Trend
Figure 73. Manufacturing Cost Structure of Animal Biological Vaccine
Figure 74. Manufacturing Process Analysis of Animal Biological Vaccine
Figure 75. Animal Biological Vaccine Industrial Chain Analysis
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Porter's Five Forces Analysis
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed